Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma—rationale for targeting ARID1A deficiency | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Stomach

Original research

Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma—rationale for targeting ARID1A deficiency

Online download statistics by month:

Online download statistics by month: March 2021 to March 2024

	Abstract	Full	Pdf
Mar 2021	343	21	18
Apr 2021	1599	183	103
May 2021	513	90	51
Jun 2021	75	60	32
Jul 2021	58	54	26
Aug 2021	50	41	39
Sep 2021	37	30	19
Oct 2021	282	31	18
Nov 2021	502	23	18
Dec 2021	408	40	22
Jan 2022	392	50	30
Feb 2022	1972	141	88
Mar 2022	1356	124	77
Apr 2022	704	76	56
May 2022	511	47	18
Jun 2022	465	54	23
Jul 2022	469	42	27
Aug 2022	519	35	20
Sep 2022	561	66	45
Oct 2022	528	52	26
Nov 2022	401	53	19
Dec 2022	247	28	10
Jan 2023	284	22	9
Feb 2023	425	28	10
Mar 2023	158	16	7
Apr 2023	161	29	20
May 2023	127	14	11
Jun 2023	95	15	9
Jul 2023	134	24	13
Aug 2023	107	12	8
Sep 2023	189	19	5
Oct 2023	129	14	5
Nov 2023	184	18	8
Dec 2023	242	20	16
Jan 2024	209	17	14
Feb 2024	113	7	8
Mar 2024	194	15	14
Total	14743	1611	942